inDividual, Targeted thrombosIS Prophylaxis Versus the Standard One Size Fits All Approach in Patients Undergoing Total hIp or Total kNee replaCemenT

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 10078 participants.

Also called NCT06581965

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 10,078 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06581965
  • EU CT 2023-510186-98-00
  • WHO UTN U1111-1305-2311
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Netherlands (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06581965. Randomized; no masking; primary purpose prevention. Start 2024-11-11 (actual); primary completion 2030-05-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
inDividual, Targeted thrombosIS Prophylaxis Versus the Standard 'One Size Fits All' Approach in Patients Undergoing Total hIp or Total kNee replaCemenT
Acronym
DISTINCT
Condition
Venous Thromboembolism
Condition
Venous Thromboses
Intervention (Other)
Short duration prophylaxis
Intervention (Other)
Higher intensity and longer duration prophylaxis
Intervention (Other)
Control
Lead sponsor
Leiden University Medical Center (class: other)

Record details

Record id
cardio:ct-nct06581965
Content hash
e843efecae8d1484232beb7ff207884cfd445058f21b6c6d917e93e637737338